心臓電気生理学

Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry

By MedXY 08/28/2026

This prospective registry reveals a significantly increased risk of stroke or transient ischemic attack within 30 days after pulsed field ablation compared to radiofrequency ablation for atrial fibrillation, highlighting important safety considerations and the need for careful surveillance.

Cardiology news

High-Repetition-Frequency Nanosecond Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: 12-Month Outcomes From the SCENA-AF Trial

By MedXY 03/03/2026

The SCENA-AF trial highlights the efficacy of nanosecond pulsed field ablation (nsPFA) for treating paroxysmal atrial fibrillation, achieving an 88.49% success rate at 12 months with minimal complications and a significant shift toward local anesthesia.

Cardiology Emergency Medicine news

Novel Handheld Assist Device Quadruples Success Rates of Valsalva Maneuver in Supraventricular Tachycardia

By MedXY 02/21/2026

A randomized clinical trial demonstrates that a handheld Valsalva assist device significantly improves sinus rhythm restoration in SVT patients compared to the standard maneuver, achieving a 63.2% success rate versus 29.2% in a clinical setting.

Cardiology news

Subcutaneous ICDs in the Real World: Lessons from the French Nationwide HONEST Study

By MedXY 01/03/2026

The nationwide HONEST study provides critical five-year data on S-ICD performance, highlighting a 13.8% inappropriate shock rate, the protective effect of SMART Pass filtering, and unexpected challenges with battery longevity in a large, unselected patient population.

$Bailout Catheter Ablation: A Lifesaving Strategy for Refractory Ventricular Tachycardia in Early Acute Myocardial Infarction$

Cardiology Critical Care news

Bailout Catheter Ablation: A Lifesaving Strategy for Refractory Ventricular Tachycardia in Early Acute Myocardial Infarction

By MedXY 01/03/2026

A clinical study demonstrates that catheter ablation is a highly effective rescue therapy for refractory, scar-related ventricular tachycardia occurring in the early phase of acute myocardial infarction, challenging traditional management timelines.